HOME >> MEDICINE >> NEWS
Newly Updated HIV Treatment Guidelines For Adults And Adolescents Available On The World Wide Web

An updated version of the Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents has been posted to the AIDS Treatment Information Service (ATIS) Web site, www.hivatis.org.

The Guidelines were developed by the Panel on Clinical Practices for the Treatment of HIV Infection, a joint effort of the Department of Health and Human Services and the Henry J. Kaiser Family Foundation. The Guidelines were constructed as a "living document" and are updated frequently by the Panel.

"We feel that the Guidelines are an invaluable resource to all health care providers who care for HIV-infected individuals," says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) and co-chair of the Panel. The Guidelines were published in hard-copy form in the Morbidity and Mortality Weekly Report and in the Annals of Internal Medicine in 1998; however, they are updated frequently on the ATIS Web site. In addition, a hard copy of the most recent version of the Guidelines can be obtained for free by calling 1-800-448-0440.

Included in the latest version of the Guidelines are recommendations for the use of the recently approved anti-HIV drug abacavir (trade name Ziagen). Abacavir is a potent anti-HIV agent belonging to a class of drugs known as nucleoside analog reverse transcriptase inhibitors. This family of drugs also includes zidovudine (AZT) and lamivudine (3TC).

Clinical trials of abacavir combined with AZT and 3TC have shown that this combination suppresses HIV replication and boosts CD4+ T-cell counts to a degree comparable to widely used treatment regimens that combine a protease inhibitor drug with AZT and 3TC. CD4+ T cells are the crucial immune system cells depleted during the course of HIV disease.

The Panel notes that the potential advantages of the abacavir+AZT+3TC regimen include ease of administration (two pills twice daily), and
'"/>

Contact: Greg Folkers
gfolkers@nih.gov
301-496-2263
NIH/National Institute of Allergy and Infectious Diseases
5-May-1999


Page: 1 2 3

Related medicine news :

1. Newly discovered pathway might help in design of cancer drugs
2. Newly identified gene cluster on mouse X chromosome provides insights into fertility
3. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
4. Newly-described route to cancer solves a mystery in lung cancer
5. Newly approved psoriasis drug invented and tested at Univ. of Michigan
6. Newly published data show at-home dialysis therapy may benefit more patients
7. Newly revised recommendations affirm medicine
8. Osteoporosis Drug Evista (Raloxifene) Cuts Newly Diagnosed, Invasive Breast Cancer Risk By More Than 60 Percent
9. For Patients With Advanced Prostate Cancer, Newly Evaluated Drug May Offer Pain Relief And Mild Delay In Disease Progression
10. Updated adjuvant data presented at SABCS show 30 percent reduction in recurrence
11. Updated press release to October 2004 Cochrane Review

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... September 01, 2020 , ... As fall and winter swiftly approach and many ... has taken this time to expand and grow into a full-fledged natural health ... Health Institute will be relaunching its brand new website, expanding its services menu and ...
(Date:8/31/2020)... ... 2020 , ... Just found out your dear friend has cancer? , It’s hard to hear ... member shares their diagnosis. Once the shock wears off, the questions and fears can be ... the best ways to help? Words are failing me. I’m scared. I want to DO ...
(Date:8/31/2020)... ... 2020 , ... Colorado State University Global (CSU Global) – ... education – is proud to announce its new master’s degree in Military ... in the nation, the 60-credit hour program is designed to provide students with ...
(Date:8/31/2020)... ... 2020 , ... In an effort to give back to the community in ... each hotel room booked with a special new rate code to benefit children and ... effective immediately. Donations will be applied to any room type, any time, now ...
(Date:8/28/2020)... ... 28, 2020 , ... Ernst & Young LLP (EY US) ... Of The Year® 2020 Florida Award finalist. Now in its 34th year, the ... growth and prosperity as they build and sustain successful businesses that transform our ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... ... August 31, 2020 , ... Continuing on its rapid ... sanitization, disinfection and deodorization provider - is proud to announce it has opened ... for businesses and residents throughout the area. , Germinator provides a 100% safe ...
(Date:8/28/2020)... ... August 28, 2020 , ... Dr. Raheleh Sarbaziha has been ... and approach. Armed with her qualifications from Ross University School of Medicine and ... the human body with the nation and world. With a fellowship in Integrative ...
(Date:8/27/2020)... ... , ... Bleep LLC, maker of the DreamPort mask-less CPAP solution, announced today ... spokesperson. , “In my line of work, a good night of sleep is critical ... was a Bleeping no brainer for me,” said Jensen. “From the moment I started ...
Breaking Medicine Technology:
Cached News: